Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796
Peter Thornton(Community Health Systems - Lutheran Hospital), Alan P. Watt(Essex Cardiothoracic Centre), Zsofia Digby(University of Chester), Pamela J. Smolak(Benjamin Franklin Institute of Technology), David Harrison(Chelmsford and Essex Hospital), Valérie Reader(Chelmsford and Essex Hospital), Nick Clarke, Nicola Lindsay
Cited by 51
Related Papers
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
|Nature Biotechnology|2011|666
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
|Journal of Medicinal Chemistry|2023|62
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
|European Journal of Pharmacology|2014|54
Myocardial Hypertrophy Resulting from Low Dosage Isoproterenol Administration in Rats
|Experimental Biology and Medicine|1971|49
Engineering transglycosidase activity into a GH51 α-l-arabinofuranosidase
|New Biotechnology|2013|35